International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 1092-1099 , 15 July 2009

Motion Analysis of 100 Mediastinal Lymph Nodes: Potential Pitfalls in Treatment Planning and Adaptive Strategies

  • Jason R. Pantarotto, M.D., F.R.C.P.C.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Anna H.M. Piet, M.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Andrew Vincent, Ph.D.

      Affiliations

    • Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • John R. van Sörnsen de Koste, Ph.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Suresh Senan, M.R.C.P., F.R.C.R., Ph.D.

      Affiliations

    • Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationReprint requests to: Suresh Senan, M.R.C.P., F.R.C.R., Ph.D., Department of Radiation Oncology, VU University Medical Center, De Boelelaan 1117, 1007 MB, Amsterdam, The Netherlands. Tel: (+31) 20-444-0414; Fax: (+3) 20-444-0497

Received 15 May 2008 ,Revised 27 July 2008 ,Accepted 28 September 2008.

References 

  1. Wisnivesky JP, Yankelevitz D, Henschke CI. Stage of lung cancer in relation to its size: Part 2. Evidence. Chest. 2005;127:1136–1139
  2. Senan S, Burgers S, Samson MJ, et al. Can elective nodal irradiation be omitted in stage III non–small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:999–1006
  3. Girinsky T, van der Maazen R, Specht L, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. Radiother Oncol. 2006;79:270–277
  4. Senan S, De Ruysscher D, Giraud P, et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol. 2004;71:139–146
  5. Underberg R, van Sornsen de Koste J, Lagerwaard F, et al. A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer. Radiat Oncol. 2006;1:8
  6. Jenkins P, Salmon C, Mannion C. Analysis of the movement of calcified lymph nodes during breathing. Int J Radiat Oncol Biol Phys. 2005;61:329–334
  7. van Sornsen de Koste J, Lagerwaard FJ, Nijssen-Visser MRJ, et al. What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer?. Int J Radiat Oncol Biol Phys. 2002;53:1211–1215
  8. Piet AHM, Lagerwaard FJ, Kunst PWA, et al. Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging?. Chest. 2007;131:1783–1787
  9. Donnelly ED, Parikh PJ, Lu W, et al. Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT. Int J Radiat Oncol Biol Phys. 2007;69:580–588
  10. Sher DJ, Wolfgang JA, Niemierko A, et al. Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: Implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2007;69:1402–1408
  11. Bosmans G, van Baardwijk A, Dekker A, et al. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non–small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;71:139–144
  12. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys. 2006;33:3874–3900
  13. Rosenzweig KE, Sura S, Jackson A, et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol. 2007;25:5557–5561
  14. Yuan SH, Sun XD, Li MH, et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol. 2007;30:239–244
  15. Lagerwaard FJ, Senan S. Lung cancer: Intensity-modulated radiation therapy, four-dimensional imaging and mobility management. Front Radiat Ther Oncol. 2007;40:239–252
  16. Verellen D, Ridder MD, Linthout N, et al. Innovations in image-guided radiotherapy. Nat Rev Cancer. 2007;7:949–960
  17. Underberg RW, Lagerwaard FJ, Cuijpers JP, et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:1283–1290
  18. Pan T, Lee TY, Rietzel E, et al. 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT. Med Phys. 2004;31:333–340
  19. van Sornsen de Koste JR, Senan S, Kleynen CE, et al. Renal mobility during uncoached quiet respiration: An analysis of 4DCT scans. Int J Radiat Oncol Biol Phys. 2006;64:799–803
  20. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
  21. Chapet O, Kong FM, Quint LE, et al. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys. 2005;63:170–178
  22. van Sornsen de Koste JR, Senan S, Underberg RW, et al. Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for stage III NSCLC. Int J Radiat Oncol Biol Phys. 2005;63:334–339
  23. Robinson LA, Ruckdeschel JC, Wagner H, et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines. Chest. 2007;132(Suppl.):S243–S265
  24. Weiss E, Wijesooriya K, Dill SV, et al. Tumor and normal tissue motion in the thorax during respiration: Analysis of volumetric and positional variations using 4D CT. Int J Radiat Oncol Biol Phys. 2007;67:296–307
  25. Liu HH, Balter P, Tutt T, et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 2007;68:531–540
  26. Lee YC, Wu CT, Kuo SW, et al. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest. 2007;131:993–999
  27. Yuan SH, Meng X, Yu JM, et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:727–734
  28. Ahn SJ, Kahn D, Zhou SM, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys. 2005;61:335–347
  29. Wolthaus JW, Sonke JJ, van HM, et al. Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. Int J Radiat Oncol Biol Phys. 2008;70:1229–1238

 Research funding for J.R.P. has been provided by the Canadian Association of Radiation Oncology in partnership with Elekta and the University of Ottawa.

 Accepted for presentation at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), September 21–25, 2008, Boston, MA.

 Conflict of interest: none.

PII: S0360-3016(08)03487-1

doi: 10.1016/j.ijrobp.2008.09.031

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 4 , Pages 1092-1099 , 15 July 2009

Article Tools

* Image Usage & Resolution